His father was Isidore Edelman, a physician and researcher who became chair of the biochemistry and molecular biophysics department at Columbia University.

To help mitigate day-to-day volatility, it has set a maximum daily loss allowance of five percent on long and short positions.

It would invest in vehicles such as direct secured loans, royalties and convertible structures for public and private companies.

[2][4] In August 2018, Institutional Investor stated that Perceptive since inception only had two years of negative returns.

[7][8][9] In September 2022, the U.S. Securities and Exchange Commission sued Perceptive for failing to disclose conflicts of interest related to special-purpose acquisition companies (SPACs).